miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis

Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover

(2018) Fei Gao et al.   BRITISH JOURNAL OF CANCER

MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis

(2018) Wei Yang et al.   GENE

Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways

(2018) Hui Zhou et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells

(2018) Emily A. Teslow et al.   Molecular Oncology

MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3

(2017) Yuan Xiang et al.   EXPERIMENTAL CELL RESEARCH

Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation

(2017) Anne L. van de Ven et al.   MOLECULAR CANCER THERAPEUTICS

TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer

(2017) M K Siu et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas

(2017) Jaegil Kim et al.   International Journal of Genomics

Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer

(2016) Andrew S. McDaniel et al.   BJU INTERNATIONAL

Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors

(2016) Savita Singh et al.   CANCER LETTERS

Lectin-induced agglutination of urinary exosomes followed by mi-RNA analysis: Application for prostate cancer diagnostics

(2016) A. Nosov et al.   EUROPEAN UROLOGY SUPPLEMENTS

Detection of miRNAs in urine of prostate cancer patients

(2016) Kristina Stuopelytė et al.   Medicina-Lithuania

Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data

(2016) Yanan Sun et al.   UROLOGY

Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP

(2016) Ming Wei et al.   Oncotarget

Detection of miRNAs in urine of prostate cancer patients

(2016) Kristina Stuopelytė et al.   Medicina-Lithuania

MiRNA inhibition in tissue engineering and regenerative medicine

(2015) Kelsey R. Beavers et al.   ADVANCED DRUG DELIVERY REVIEWS

Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities

(2015) B.-D. Wang et al.   CLINICAL CANCER RESEARCH

The Role of miRNAs in Prostate Cancer

(2015) Tong Sun et al.   EUROPEAN UROLOGY

Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management

(2015) Moein Amin et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets

(2015) Carolyn M. Klinge   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein–Barr virus and human papillomaviruses: With special reference to oral cancer

(2015) Jatinder Pal Singh Chawla et al.   ORAL ONCOLOGY

The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model

(2015) Yu-Yu Kao et al.   ORAL ONCOLOGY

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression

(2015) Nahyun Choi et al.   Oncotarget

Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network

(2015) Jin Zhu et al.   Oncotarget

Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs

(2014) Kati Erdmann et al.   BMC CANCER

AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer

(2014) C. Priolo et al.   CANCER RESEARCH

5′ isomiR variation is of functional and evolutionary importance

(2014) Geok Chin Tan et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo

(2014) T-I Hsu et al.   Oncogenesis

External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort

(2012) Yao Zhu et al.   ASIAN JOURNAL OF ANDROLOGY

Wnt/β-catenin signalling in prostate cancer

(2012) Robert M. Kypta et al.   Nature Reviews Urology

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing

(2010) J. Szczyrba et al.   MOLECULAR CANCER RESEARCH

New Tricks for Animal MicroRNAs: Targeting of Amino Acid Coding Regions at Conserved and Nonconserved Sites

(2009) I. Rigoutsos   CANCER RESEARCH

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation

(2009) K-H Lee et al.   ONCOGENE

Purine-rich element binding protein (PUR) α induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells

(2009) Takahiro Inoue et al.   PROSTATE

MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation

(2008) Yvonne Tay et al.   NATURE